AtriCure, Inc. (NASDAQ: ATRC), the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS). This landmark three-year, ...
Atrial fibrillation (Afib) is one of the most common heart rhythm disorders, affecting millions worldwide. It occurs when the upper chambers of the heart (atria) beat irregularly and out of sync with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results